Currently Viewing:
Newsroom
Currently Reading
CRISPR-Gene Editing Technology Successfully Treated Lethal Lung Disease in Animal Models
April 20, 2019 – Samantha DiGrande
Study Finds Patients Misdiagnosed With MS Increases Morbidity, Healthcare Costs
April 19, 2019 – Samantha DiGrande
Sensor-based Algorithm Detects Patient Response to Parkinson Therapies
April 19, 2019 – Samantha DiGrande
Analyzing the Scent of Parkinson Disease Could Lead to Diagnostic Tool
April 19, 2019 – Wallace Stephens
This Week in Managed Care: April 19, 2019
April 19, 2019
ctDNA Can Detect MRD and Early Cancer Recurrence in Colorectal Cancer
April 19, 2019 – Laura Joszt
5 Findings From the April 2019 Issue of AJMC®
April 19, 2019 – Christina Mattina
What We're Reading: Long-Term Care Benefits; Predicting Obesity; Montana Reauthorizes Medicaid Expansion
April 19, 2019 – AJMC Staff
AJMC® in the Press, April 19, 2019
April 19, 2019 – AJMC Staff

What We're Reading: Ark. Work Requirements Lawsuit; CVS' Cost Savings Plan; Kavanaugh and Healthcare

AJMC Staff
Advocacy groups filed a lawsuit on behalf of 3 Medicaid recipients challenging Arkansas' Medicaid work requirements; CVS Health announced that its pharmacy benefit manager will target expensive drugs to be excluded from formularies if they are not cost effective; Senate leaders have received a letter from 120 consumer and patient associations on the impact Supreme Court nominee Brett Kavanaugh could have on health policy.

Arkansas Medicaid Recipients File Lawsuit Over Work Requirements

The Trump administration is facing another lawsuit over its decision to allow states to impose work requirements in Medicaid. Similar to an earlier lawsuit over Kentucky’s work requirements, advocacy groups filed a lawsuit on behalf of 3 Medicaid recipients in Arkansas, reported Reuters. The lawsuit claims the administration does not have the capability to approve work requirements under the federal Medicaid law. In June, a federal judge blocked Kentucky’s work requirements.

 

CVS Program Will Allow Expensive Drugs to Be Excluded

In a recent white paper, CVS Health announced that its pharmacy benefit manager will target expensive drugs to be excluded from formularies if they are not cost effective. According to The Center for Biosimilars®, a sister site of The American Journal of Managed Care®, CVS Caremark will rely on data from the Institute for Clinical and Economic Review to determine cost effectiveness. CVS has already implemented efforts to curb costs, and the white paper identifies 3 additional strategies it will begin to employ.

 

Consumer and Patient Associations Weigh in on Kavanaugh

Senate leaders have received a letter from 120 consumer and patient associations on the impact Supreme Court nominee Brett Kavanaugh could have on health policy. InsideHealth Policy reported that the Supreme Court might be hearing cases on the constitutionality of the Affordable Care Act, access to women’s healthcare services, state accountability for violating Medicaid requirements, and attempts to roll back Medicaid coverage. Kavanaugh could be a deciding vote on all of these health issues.

Related Articles

CVS Launches Tool Enabling Pharmacists to Help Patients Save Money on Drugs
5 Things to Know About SCOTUS Nominee Brett Kavanaugh's Healthcare Views
As States Impose Medicaid Work Requirements, an Analysis Finds Little Evidence That Employment Improves Health
What Do Arkansas Medicaid Work Requirements Say About Future Coverage?
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up